25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

OpGen Inc
Buy, Hold or Sell?

Let's analyze Opgen together

I guess you are interested in OpGen Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of OpGen Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about OpGen Inc

I send you an email if I find something interesting about OpGen Inc.

1. Quick Overview

1.1. Quick analysis of Opgen (30 sec.)










1.2. What can you expect buying and holding a share of Opgen? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
2.5%

What is your share worth?

Current worth
$-1.40
Expected worth in 1 year
$-3.61
How sure are you?
32.5%

+ What do you gain per year?

Total Gains per Share
$-2.22
Return On Investment
-99.0%

For what price can you sell your share?

Current Price per Share
$2.24
Expected price per share
$1.65 - $2.9
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Opgen (5 min.)




Live pricePrice per Share (EOD)
$2.24
Intrinsic Value Per Share
$-13.36 - $35.75
Total Value Per Share
$-14.76 - $34.35

2.2. Growth of Opgen (5 min.)




Is Opgen growing?

Current yearPrevious yearGrowGrow %
How rich?-$11.6m$9.3m-$17.4m-216.9%

How much money is Opgen making?

Current yearPrevious yearGrowGrow %
Making money-$9.9m-$9.3m-$551.7k-5.6%
Net Profit Margin-2,349.3%-1,554.3%--

How much money comes from the company's main activities?

2.3. Financial Health of Opgen (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Opgen?

Welcome investor! Opgen's management wants to use your money to grow the business. In return you get a share of Opgen.

First you should know what it really means to hold a share of Opgen. And how you can make/lose money.

Speculation

The Price per Share of Opgen is $2.24. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Opgen.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Opgen, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-1.40. Based on the TTM, the Book Value Change Per Share is $-0.55 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.61 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Opgen.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.19-8.4%-1.19-53.1%-1.08-48.4%-0.97-43.5%-0.73-32.5%
Usd Book Value Change Per Share-0.01-0.6%-0.55-24.7%-0.61-27.4%-0.08-3.6%-0.04-1.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.041.9%0.021.0%
Usd Total Gains Per Share-0.01-0.6%-0.55-24.7%-0.61-27.4%-0.04-1.7%-0.01-0.6%
Usd Price Per Share2.58-1.02-0.64-1.68-1.44-
Price to Earnings Ratio-3.42--0.94--0.21--0.77--0.69-
Price-to-Total Gains Ratio-202.19--67.75-0.91--11.74--9.39-
Price to Book Ratio-1.85--0.35-0.63--1.41-0.57-
Price-to-Total Gains Ratio-202.19--67.75-0.91--11.74--9.39-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.24
Number of shares446
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.04
Usd Book Value Change Per Share-0.55-0.08
Usd Total Gains Per Share-0.55-0.04
Gains per Quarter (446 shares)-247.25-16.89
Gains per Year (446 shares)-988.99-67.56
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-989-99977-144-78
20-1978-1988153-288-146
30-2967-2977230-432-214
40-3956-3966306-576-282
50-4945-4955383-720-350
60-5934-5944459-864-418
70-6923-6933536-1008-486
80-7912-7922612-1153-554
90-8901-8911689-1297-622
100-9890-9900765-1441-690

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.040.00.00.0%0.043.00.00.0%
Book Value Change Per Share0.03.01.00.0%2.09.01.016.7%7.012.01.035.0%13.026.01.032.5%14.026.03.032.6%
Dividend per Share0.00.04.00.0%1.00.011.08.3%1.00.019.05.0%1.00.039.02.5%1.00.042.02.3%
Total Gains per Share0.03.01.00.0%2.09.01.016.7%7.012.01.035.0%13.026.01.032.5%14.026.03.032.6%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of OpGen Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.013-0.554+4245%-0.613+4707%-0.081+533%-0.035+178%
Book Value Per Share---1.396-0.961-31%1.124-224%1.802-178%1.080-229%
Current Ratio--0.0450.150-70%0.987-95%1.797-97%1.623-97%
Debt To Asset Ratio--5.0665.051+0%0.658+670%1.467+245%1.256+303%
Debt To Equity Ratio---1.444-100%1.983-100%1.230-100%1.453-100%
Dividend Per Share----0%-0%0.043-100%0.021-100%
Eps---0.189-1.189+530%-1.083+474%-0.974+417%-0.727+286%
Free Cash Flow Per Share---0.086-0.213+147%-0.589+583%-0.546+534%-0.472+447%
Free Cash Flow To Equity Per Share---0.012-0.068+469%-0.398+3248%0.014-182%0.010-217%
Gross Profit Margin--1.0161.029-1%1.131-10%1.106-8%1.161-12%
Intrinsic Value_10Y_max--35.747--------
Intrinsic Value_10Y_min---13.362--------
Intrinsic Value_1Y_max---1.096--------
Intrinsic Value_1Y_min---1.820--------
Intrinsic Value_3Y_max--0.272--------
Intrinsic Value_3Y_min---5.084--------
Intrinsic Value_5Y_max--5.939--------
Intrinsic Value_5Y_min---7.902--------
Market Cap18716320.000-15%21557190.0008555196.450+152%5372795.388+301%14026085.408+54%12025026.713+79%
Net Profit Margin---56.298-23.493-58%-15.543-72%-12.465-78%-8.623-85%
Operating Margin---56.266-15.763-72%-8.573-85%-8.490-85%-6.484-88%
Operating Ratio--56.26117.252+226%9.362+501%9.359+501%7.368+664%
Pb Ratio-1.604+13%-1.848-0.351-81%0.633-392%-1.410-24%0.565-427%
Pe Ratio-2.968+13%-3.419-0.940-72%-0.212-94%-0.774-77%-0.686-80%
Price Per Share2.240-15%2.5801.024+152%0.643+301%1.679+54%1.439+79%
Price To Free Cash Flow Ratio-6.497+13%-7.483-2.287-69%-0.262-97%-1.254-83%-0.993-87%
Price To Total Gains Ratio-175.549+13%-202.195-67.747-66%0.910-22328%-11.744-94%-9.392-95%
Quick Ratio--0.0150.048-68%0.716-98%1.547-99%1.392-99%
Return On Assets---0.549-4.720+759%-0.339-38%-1.122+104%-0.798+45%
Return On Equity----0.3790%-0.9960%-0.4430%-0.8140%
Total Gains Per Share---0.013-0.554+4245%-0.613+4707%-0.038+197%-0.014+10%
Usd Book Value---11668200.000-8028661.250-31%9387832.500-224%15053487.000-178%9019934.225-229%
Usd Book Value Change Per Share---0.013-0.554+4245%-0.613+4707%-0.081+533%-0.035+178%
Usd Book Value Per Share---1.396-0.961-31%1.124-224%1.802-178%1.080-229%
Usd Dividend Per Share----0%-0%0.043-100%0.021-100%
Usd Eps---0.189-1.189+530%-1.083+474%-0.974+417%-0.727+286%
Usd Free Cash Flow---720212.000-1776139.000+147%-4917242.500+583%-4565887.950+534%-3939840.000+447%
Usd Free Cash Flow Per Share---0.086-0.213+147%-0.589+583%-0.546+534%-0.472+447%
Usd Free Cash Flow To Equity Per Share---0.012-0.068+469%-0.398+3248%0.014-182%0.010-217%
Usd Market Cap18716320.000-15%21557190.0008555196.450+152%5372795.388+301%14026085.408+54%12025026.713+79%
Usd Price Per Share2.240-15%2.5801.024+152%0.643+301%1.679+54%1.439+79%
Usd Profit---1576349.000-9930650.000+530%-9378858.750+495%-7925958.000+403%-5831486.175+270%
Usd Revenue--28000.000716615.000-96%704981.000-96%855635.050-97%861002.375-97%
Usd Total Gains Per Share---0.013-0.554+4245%-0.613+4707%-0.038+197%-0.014+10%
 EOD+2 -6MRQTTM+20 -13YOY+19 -145Y+18 -1710Y+18 -17

3.3 Fundamental Score

Let's check the fundamental score of OpGen Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.968
Price to Book Ratio (EOD)Between0-1-1.604
Net Profit Margin (MRQ)Greater than0-56.298
Operating Margin (MRQ)Greater than0-56.266
Quick Ratio (MRQ)Greater than10.015
Current Ratio (MRQ)Greater than10.045
Debt to Asset Ratio (MRQ)Less than15.066
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.549
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of OpGen Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.038
Ma 20Greater thanMa 502.024
Ma 50Greater thanMa 1002.481
Ma 100Greater thanMa 2003.061
OpenGreater thanClose2.060
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About OpGen Inc

OpGen, Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally. The company's products include Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel test products, and SARS CoV-2 test kits. It provides laboratory services; collaboration services, including funded software arrangements; and license arrangements services. OpGen, Inc. was incorporated in 2001 and is headquartered in Rockville, Maryland.

Fundamental data was last updated by Penke on 2024-09-12 11:50:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Opgen earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Opgen to the Medical Devices industry mean.
  • A Net Profit Margin of -5,629.8% means that $-56.30 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of OpGen Inc:

  • The MRQ is -5,629.8%. The company is making a huge loss. -2
  • The TTM is -2,349.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-5,629.8%TTM-2,349.3%-3,280.5%
TTM-2,349.3%YOY-1,554.3%-795.1%
TTM-2,349.3%5Y-1,246.5%-1,102.8%
5Y-1,246.5%10Y-862.3%-384.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-5,629.8%-11.4%-5,618.4%
TTM-2,349.3%-16.0%-2,333.3%
YOY-1,554.3%-16.9%-1,537.4%
5Y-1,246.5%-17.8%-1,228.7%
10Y-862.3%-23.4%-838.9%
4.3.1.2. Return on Assets

Shows how efficient Opgen is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Opgen to the Medical Devices industry mean.
  • -54.9% Return on Assets means that Opgen generated $-0.55 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of OpGen Inc:

  • The MRQ is -54.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -472.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-54.9%TTM-472.0%+417.1%
TTM-472.0%YOY-33.9%-438.1%
TTM-472.0%5Y-112.2%-359.8%
5Y-112.2%10Y-79.8%-32.4%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-54.9%-3.3%-51.6%
TTM-472.0%-3.9%-468.1%
YOY-33.9%-3.8%-30.1%
5Y-112.2%-3.2%-109.0%
10Y-79.8%-3.9%-75.9%
4.3.1.3. Return on Equity

Shows how efficient Opgen is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Opgen to the Medical Devices industry mean.
  • 0.0% Return on Equity means Opgen generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of OpGen Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-37.9%+37.9%
TTM-37.9%YOY-99.6%+61.7%
TTM-37.9%5Y-44.3%+6.4%
5Y-44.3%10Y-81.4%+37.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--3.9%+3.9%
TTM-37.9%-4.3%-33.6%
YOY-99.6%-4.5%-95.1%
5Y-44.3%-4.6%-39.7%
10Y-81.4%-5.5%-75.9%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of OpGen Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Opgen is operating .

  • Measures how much profit Opgen makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Opgen to the Medical Devices industry mean.
  • An Operating Margin of -5,626.6% means the company generated $-56.27  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of OpGen Inc:

  • The MRQ is -5,626.6%. The company is operating very inefficient. -2
  • The TTM is -1,576.3%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-5,626.6%TTM-1,576.3%-4,050.3%
TTM-1,576.3%YOY-857.3%-719.0%
TTM-1,576.3%5Y-849.0%-727.3%
5Y-849.0%10Y-648.4%-200.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-5,626.6%-15.5%-5,611.1%
TTM-1,576.3%-21.5%-1,554.8%
YOY-857.3%-11.8%-845.5%
5Y-849.0%-17.4%-831.6%
10Y-648.4%-22.1%-626.3%
4.3.2.2. Operating Ratio

Measures how efficient Opgen is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 56.26 means that the operating costs are $56.26 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of OpGen Inc:

  • The MRQ is 56.261. The company is inefficient in keeping operating costs low. -1
  • The TTM is 17.252. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ56.261TTM17.252+39.009
TTM17.252YOY9.362+7.890
TTM17.2525Y9.359+7.893
5Y9.35910Y7.368+1.991
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ56.2611.384+54.877
TTM17.2521.380+15.872
YOY9.3621.404+7.958
5Y9.3591.411+7.948
10Y7.3681.375+5.993
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of OpGen Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Opgen is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 0.05 means the company has $0.05 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of OpGen Inc:

  • The MRQ is 0.045. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.150. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.045TTM0.150-0.104
TTM0.150YOY0.987-0.837
TTM0.1505Y1.797-1.648
5Y1.79710Y1.623+0.175
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0452.587-2.542
TTM0.1502.627-2.477
YOY0.9873.001-2.014
5Y1.7973.424-1.627
10Y1.6233.519-1.896
4.4.3.2. Quick Ratio

Measures if Opgen is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Opgen to the Medical Devices industry mean.
  • A Quick Ratio of 0.02 means the company can pay off $0.02 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of OpGen Inc:

  • The MRQ is 0.015. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.048. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.015TTM0.048-0.033
TTM0.048YOY0.716-0.668
TTM0.0485Y1.547-1.499
5Y1.54710Y1.392+0.154
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0151.272-1.257
TTM0.0481.492-1.444
YOY0.7161.910-1.194
5Y1.5472.331-0.784
10Y1.3922.573-1.181
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of OpGen Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Opgen assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Opgen to Medical Devices industry mean.
  • A Debt to Asset Ratio of 5.07 means that Opgen assets are financed with 506.6% credit (debt) and the remaining percentage (100% - 506.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of OpGen Inc:

  • The MRQ is 5.066. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 5.051. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ5.066TTM5.051+0.015
TTM5.051YOY0.658+4.393
TTM5.0515Y1.467+3.584
5Y1.46710Y1.256+0.211
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ5.0660.402+4.664
TTM5.0510.404+4.647
YOY0.6580.359+0.299
5Y1.4670.440+1.027
10Y1.2560.462+0.794
4.5.4.2. Debt to Equity Ratio

Measures if Opgen is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Opgen to the Medical Devices industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of OpGen Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM1.444-1.444
TTM1.444YOY1.983-0.540
TTM1.4445Y1.230+0.213
5Y1.23010Y1.453-0.222
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.558-0.558
TTM1.4440.589+0.855
YOY1.9830.535+1.448
5Y1.2300.612+0.618
10Y1.4530.688+0.765
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Opgen generates.

  • Above 15 is considered overpriced but always compare Opgen to the Medical Devices industry mean.
  • A PE ratio of -3.42 means the investor is paying $-3.42 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of OpGen Inc:

  • The EOD is -2.968. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.419. Based on the earnings, the company is expensive. -2
  • The TTM is -0.940. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.968MRQ-3.419+0.451
MRQ-3.419TTM-0.940-2.478
TTM-0.940YOY-0.212-0.729
TTM-0.9405Y-0.774-0.167
5Y-0.77410Y-0.686-0.088
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-2.968-1.071-1.897
MRQ-3.419-1.367-2.052
TTM-0.940-2.172+1.232
YOY-0.212-2.347+2.135
5Y-0.774-2.241+1.467
10Y-0.686-2.020+1.334
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of OpGen Inc:

  • The EOD is -6.497. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -7.483. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.287. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6.497MRQ-7.483+0.986
MRQ-7.483TTM-2.287-5.196
TTM-2.287YOY-0.262-2.025
TTM-2.2875Y-1.254-1.033
5Y-1.25410Y-0.993-0.261
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-6.497-1.523-4.974
MRQ-7.483-2.128-5.355
TTM-2.287-1.907-0.380
YOY-0.262-5.889+5.627
5Y-1.254-4.727+3.473
10Y-0.993-5.319+4.326
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Opgen is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of -1.85 means the investor is paying $-1.85 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of OpGen Inc:

  • The EOD is -1.604. Based on the equity, the company is expensive. -2
  • The MRQ is -1.848. Based on the equity, the company is expensive. -2
  • The TTM is -0.351. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.604MRQ-1.848+0.243
MRQ-1.848TTM-0.351-1.497
TTM-0.351YOY0.633-0.983
TTM-0.3515Y-1.410+1.059
5Y-1.41010Y0.565-1.975
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-1.6042.094-3.698
MRQ-1.8482.057-3.905
TTM-0.3512.299-2.650
YOY0.6333.008-2.375
5Y-1.4104.148-5.558
10Y0.5654.774-4.209
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of OpGen Inc.

4.8.1. Institutions holding OpGen Inc

Institutions are holding 0.057% of the shares of OpGen Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-03-31Chase Investment Counsel Corp2.62890.08563318903318900
2024-03-31Vanguard Group Inc0.42205327500
2024-03-31Geode Capital Management, LLC0.2875036301-454-1.2352
2024-03-31BlackRock Inc0.1263015941-99-0.6172
2024-03-31Qube Research & Technologies0.0095012001000500
2024-03-31Wells Fargo & Co0.0006078-173-68.9243
2024-03-31Royal Bank of Canada0.000405000
2024-03-31Goss Wealth Management LLC0.000405000
2024-03-31UBS Group AG0.000101300
2024-03-31Bank of America Corp00110
2024-03-31Renaissance Technologies Corp000-66000-100
2024-03-31Virtu Financial LLC000-40384-100
2024-03-31Focused Wealth Strategies, INC.000-25-100
2024-03-31TWO SIGMA SECURITIES, LLC000-12102-100
Total 3.47570.0856438799+213654+48.7%

4.9.2. Funds holding OpGen Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-06-30Fidelity Extended Market Index0.51570.000169574148147.6682
2024-06-30Vanguard Institutional Extnd Mkt Idx Tr0.3950532800
2024-06-30NT Ext Equity Mkt Idx Fd - L0.23150.0001312329681914.8387
2024-06-30Northern Trust Extended Eq Market Idx0.23150.0001312329681914.8387
2023-12-31SSgA U.S. Extended Market Index Class I0.01440194400
2024-03-31NT Ext Equity Mkt Idx Fd - NL0.01380185500
2024-06-30Fidelity Total Market Index0.0225030410.33
2024-06-30Fidelity Series Total Market Index0.0203027410.3663
2024-06-30State St US Extended Mkt Indx NL Cl C0.0144019400
2024-06-30NT Ext Equity Mkt Idx Fd - DC - NL - T20.011014900
2024-05-31Fidelity Nasdaq Composite Index0.0096013000
2024-06-30BNYM Mellon SL Market Completion UC10.00750.000110100
2024-06-30Spartan Total Market Index Pool E0.006608900
2024-06-30SSgA U.S. Total Market Index Strategy0.00590802340.3509
2023-12-31NT US Market Cap Idx Fd - L0.000607500
2024-03-31NT Ext Eq Mkt Indx Fd DC Lending Tier 50.000506335
2024-06-30Spartan Extended Market Index Pool E0.001902600
2024-06-30State St US Ttl Mkt Indx SL Cl I0.001902600
2024-06-30Northern Trust Wilshire 50000.00060800
2024-06-30BNYM Mellon NSL Mkt Completion Fund Inst0.00050700
Total 1.50570.000423856+10112+42.4%

5.3. Insider Transactions

Insiders are holding 0.778% of the shares of OpGen Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-01-26Johannes BacherBUY25008.5
2021-11-18Oliver SchachtBUY100015
2021-09-15Johannes BacherBUY50030.7
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-06-302023-09-302023-12-312024-03-312024-06-30
Cost of Revenue  918-2276924861,17801,178-1,219-42



5.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets2,870
Total Liabilities14,538
Total Stockholder Equity-11,668
 As reported
Total Liabilities 14,538
Total Stockholder Equity+ -11,668
Total Assets = 2,870

Assets

Total Assets2,870
Total Current Assets573
Long-term Assets2,297
Total Current Assets
Cash And Cash Equivalents 168
Net Receivables 25
Other Current Assets 379
Total Current Assets  (as reported)573
Total Current Assets  (calculated)573
+/-0
Long-term Assets
Property Plant Equipment 1,995
Long-term Assets Other 302
Long-term Assets  (as reported)2,297
Long-term Assets  (calculated)2,297
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities12,599
Long-term Liabilities1,939
Total Stockholder Equity-11,668
Total Current Liabilities
Short-term Debt 11,531
Short Long Term Debt 11,370
Accounts payable 128
Other Current Liabilities 12,310
Total Current Liabilities  (as reported)12,599
Total Current Liabilities  (calculated)35,339
+/- 22,740
Long-term Liabilities
Capital Lease Obligations 2,099
Long-term Liabilities  (as reported)1,939
Long-term Liabilities  (calculated)2,099
+/- 160
Total Stockholder Equity
Common Stock13
Retained Earnings -306,782
Other Stockholders Equity 295,094
Total Stockholder Equity (as reported)-11,668
Total Stockholder Equity (calculated)-11,674
+/- 6
Other
Capital Stock19
Cash and Short Term Investments 168
Common Stock Shares Outstanding 1,340
Current Deferred Revenue-11,370
Liabilities and Stockholders Equity 2,870
Net Debt 13,301
Net Invested Capital -304
Net Working Capital -12,026
Property Plant and Equipment Gross 1,995
Short Long Term Debt Total 13,469



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-31
> Total Assets 
3,159
0
0
2,209
2,655
2,648
11,797
16,997
13,763
9,680
13,851
9,576
8,984
6,157
4,991
9,219
6,620
14,611
12,127
9,223
8,950
12,091
8,932
6,430
10,422
19,764
46,290
44,705
49,751
75,156
68,562
62,289
71,667
64,259
48,809
32,959
25,831
26,511
22,435
18,135
1,882
1,882
2,870
2,8701,8821,88218,13522,43526,51125,83132,95948,80964,25971,66762,28968,56275,15649,75144,70546,29019,76410,4226,4308,93212,0918,9509,22312,12714,6116,6209,2194,9916,1578,9849,57613,8519,68013,76316,99711,7972,6482,6552,209003,159
   > Total Current Assets 
1,964
1,400
0
1,436
1,713
1,255
11,268
13,435
9,891
5,990
10,303
6,016
5,682
2,960
1,626
6,126
3,502
11,630
9,085
6,039
5,783
7,486
4,575
2,005
6,667
17,145
16,827
14,959
16,888
42,774
35,070
29,780
39,743
33,493
20,209
13,392
10,655
10,740
7,229
3,455
1,580
1,580
573
5731,5801,5803,4557,22910,74010,65513,39220,20933,49339,74329,78035,07042,77416,88814,95916,82717,1456,6672,0054,5757,4865,7836,0399,08511,6303,5026,1261,6262,9605,6826,01610,3035,9909,89113,43511,2681,2551,7131,43601,4001,964
       Cash And Cash Equivalents 
1,400
-1,400
0
782
750
632
10,216
11,187
7,814
3,968
8,025
4,261
4,117
1,670
212
4,854
1,847
10,292
7,429
4,736
4,572
6,012
3,056
626
2,708
11,469
12,887
10,488
13,360
39,397
31,182
25,352
36,080
30,653
16,587
10,276
7,440
7,039
3,237
293
1,152
1,152
168
1681,1521,1522933,2377,0397,44010,27616,58730,65336,08025,35231,18239,39713,36010,48812,88711,4692,7086263,0566,0124,5724,7367,42910,2921,8474,8542121,6704,1174,2618,0253,9687,81411,18710,2166327507820-1,4001,400
       Short-term Investments 
0
2,801
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000002,8010
       Net Receivables 
242
0
0
184
504
92
214
554
679
642
872
447
542
379
412
470
810
591
516
316
374
813
773
377
3,089
4,975
231
423
653
486
473
751
1,172
266
738
665
514
667
620
423
103
103
25
251031034236206675146657382661,1727514734866534232314,9753,0893777738133743165165918104704123795424478726426795542149250418400242
       Inventory 
176
0
0
379
370
321
347
1,155
826
924
844
830
692
643
579
461
533
509
614
530
544
499
567
468
473
437
2,898
2,975
1,486
1,417
1,334
1,357
1,239
1,361
1,197
772
1,345
1,578
1,735
1,198
0
0
0
0001,1981,7351,5781,3457721,1971,3611,2391,3571,3341,4171,4862,9752,8984374734685674995445306145095334615796436928308449248261,15534732137037900176
       Other Current Assets 
146
0
0
91
90
210
490
538
572
456
562
479
330
268
423
341
312
238
525
458
293
162
178
533
397
264
810
1,072
1,388
1,473
2,082
2,320
1,250
1,212
1,688
1,679
1,356
1,456
1,638
1,541
325
325
379
3793253251,5411,6381,4561,3561,6791,6881,2121,2502,3202,0821,4731,3881,072810264397533178162293458525238312341423268330479562456572538490210909100146
   > Long-term Assets 
1,194
-1,400
0
773
941
1,393
530
3,563
3,871
3,690
3,548
3,559
3,302
3,196
3,365
3,093
3,118
2,981
3,041
3,184
3,167
4,605
4,358
4,425
3,755
2,619
29,464
29,746
32,863
32,382
33,492
32,509
31,924
30,767
28,599
19,568
15,175
15,772
15,205
14,680
302
302
2,297
2,29730230214,68015,20515,77215,17519,56828,59930,76731,92432,50933,49232,38232,86329,74629,4642,6193,7554,4254,3584,6053,1673,1843,0412,9813,1183,0933,3653,1963,3023,5593,5483,6903,8713,5635301,3939417730-1,4001,194
       Property Plant Equipment 
1,079
0
0
701
588
569
483
1,022
1,075
997
922
863
801
744
784
750
836
828
932
1,150
1,222
2,756
2,564
2,513
2,133
1,815
5,937
5,316
5,791
6,372
6,488
6,317
5,917
5,479
4,811
4,532
4,938
5,809
5,893
5,737
0
0
1,995
1,995005,7375,8935,8094,9384,5324,8115,4795,9176,3176,4886,3725,7915,3165,9371,8152,1332,5132,5642,7561,2221,1509328288367507847448018639229971,0751,022483569588701001,079
       Goodwill 
0
0
0
0
0
0
0
292
638
601
601
601
601
601
601
601
601
601
601
601
601
601
601
601
601
601
7,651
8,058
8,025
7,694
7,791
7,606
7,453
7,317
6,885
0
0
0
0
0
0
0
0
000000006,8857,3177,4537,6067,7917,6948,0258,0587,6516016016016016016016016016016016016016016016016016016382920000000
       Intangible Assets 
58
0
0
14
0
0
0
1,956
1,889
1,822
1,755
1,688
1,621
1,554
1,487
1,420
1,353
1,286
1,219
1,152
1,085
1,018
951
885
818
818
15,567
16,072
16,581
15,657
15,662
15,050
14,530
14,054
12,969
12,001
7,441
7,398
7,206
6,842
0
0
0
0006,8427,2067,3987,44112,00112,96914,05414,53015,05015,66215,65716,58116,07215,5678188188859511,0181,0851,1521,2191,2861,3531,4201,4871,5541,6211,6881,7551,8221,8891,956000140058
       Long-term Assets Other 
57
-1,400
0
57
354
825
46
293
270
271
270
408
280
298
493
322
329
266
289
281
259
230
241
427
203
203
309
301
2,466
2,659
3,551
3,536
4,024
3,917
3,934
3,034
2,796
2,564
2,107
2,101
302
302
302
3023023022,1012,1072,5642,7963,0343,9343,9174,0243,5363,5512,6592,46630130920320342724123025928128926632932249329828040827027127029346825354570-1,40057
> Total Liabilities 
2,990
0
0
4,288
10,721
11,462
2,969
5,053
6,272
6,425
5,906
6,300
5,817
5,603
7,129
5,458
5,219
5,311
5,728
5,193
5,642
7,752
7,105
7,987
6,128
5,681
27,562
27,626
28,560
29,124
28,826
28,990
30,449
30,088
21,448
19,021
18,255
17,334
15,575
15,458
13,444
13,444
14,538
14,53813,44413,44415,45815,57517,33418,25519,02121,44830,08830,44928,99028,82629,12428,56027,62627,5625,6816,1287,9877,1057,7525,6425,1935,7285,3115,2195,4587,1295,6035,8176,3005,9066,4256,2725,0532,96911,46210,7214,288002,990
   > Total Current Liabilities 
2,756
0
0
4,129
6,022
6,562
2,758
3,735
4,894
4,692
4,159
5,694
5,272
5,121
5,514
4,991
4,790
4,744
4,268
3,865
4,381
5,483
5,159
6,434
4,939
4,913
9,467
8,607
7,372
6,573
4,857
19,166
19,917
19,013
14,394
12,012
10,590
8,636
12,416
12,472
11,422
11,422
12,599
12,59911,42211,42212,47212,4168,63610,59012,01214,39419,01319,91719,1664,8576,5737,3728,6079,4674,9134,9396,4345,1595,4834,3813,8654,2684,7444,7904,9915,5145,1215,2725,6944,1594,6924,8943,7352,7586,5626,0224,129002,756
       Short-term Debt 
10
0
0
1,608
3,105
3,626
121
228
252
242
412
1,308
1,208
1,169
799
1,260
1,166
1,175
725
830
798
1,771
1,879
2,124
1,970
1,813
3,083
2,647
1,930
1,315
971
15,348
15,022
14,869
11,298
8,696
7,404
5,463
9,711
9,722
0
11,022
11,531
11,53111,02209,7229,7115,4637,4048,69611,29814,86915,02215,3489711,3151,9302,6473,0831,8131,9702,1241,8791,7717988307251,1751,1661,2607991,1691,2081,3084122422522281213,6263,1051,6080010
       Short Long Term Debt 
0
0
0
0
5
0
0
0
1,574
0
0
0
1,355
1,169
1,976
1,380
1,296
1,480
1,954
0
0
348
343
508
374
348
1,378
1,157
699
282
0
14,668
14,519
14,395
10,887
8,343
7,024
4,959
9,191
9,200
10,874
10,920
11,370
11,37010,92010,8749,2009,1914,9597,0248,34310,88714,39514,51914,66802826991,1571,378348374508343348001,9541,4801,2961,3801,9761,1691,3550001,57400050000
       Accounts payable 
869
0
0
899
1,160
1,059
1,116
1,275
2,286
2,206
1,901
1,936
2,233
2,017
2,907
1,939
1,692
1,444
1,283
1,036
1,624
1,529
1,259
1,873
1,056
1,054
1,745
1,240
1,869
1,249
1,207
1,147
1,307
865
732
683
421
267
195
905
111
111
128
1281111119051952674216837328651,3071,1471,2071,2491,8691,2401,7451,0541,0561,8731,2591,5291,6241,0361,2831,4441,6921,9392,9072,0172,2331,9361,9012,2062,2861,2751,1161,0591,16089900869
       Other Current Liabilities 
1,877
0
0
1,622
1,417
1,602
1,287
2,073
2,305
2,192
1,740
2,386
1,794
1,903
1,771
1,760
1,908
2,102
2,246
1,989
1,944
2,173
2,011
2,428
1,903
2,035
4,245
4,668
3,564
3,998
2,679
2,672
3,588
3,278
2,363
2,438
2,624
2,861
2,482
1,651
0
263
12,310
12,31026301,6512,4822,8612,6242,4382,3633,2783,5882,6722,6793,9983,5644,6684,2452,0351,9032,4282,0112,1731,9441,9892,2462,1021,9081,7601,7711,9031,7942,3861,7402,1922,3052,0731,2871,6021,4171,622001,877
   > Long-term Liabilities 
235
0
0
159
4,699
4,900
211
1,318
1,378
1,734
1,748
606
545
482
1,615
467
429
567
1,460
1,329
1,261
2,269
1,946
1,553
1,190
768
18,095
19,019
21,188
22,551
23,969
9,824
10,533
11,075
7,054
7,009
7,664
8,698
3,160
2,986
2,022
2,022
1,939
1,9392,0222,0222,9863,1608,6987,6647,0097,05411,07510,5339,82423,96922,55121,18819,01918,0957681,1901,5531,9462,2691,2611,3291,4605674294671,6154825456061,7481,7341,3781,3182114,9004,69915900235
       Long term Debt Total 
0
0
0
0
0
164
0
0
0
0
0
0
0
0
904
0
0
0
826
660
660
494
495
329
329
163
16,795
18,159
19,379
19,431
20,671
0
0
0
0
0
0
0
0
0
0
0
0
00000000000020,67119,43119,37918,15916,7951633293294954946606608260009040000000016400000
       Long term Debt 
234
0
0
0
134
164
211
1,000
1,327
1,272
1,219
184
147
108
904
120
130
305
826
660
660
494
495
329
329
163
16,795
18,159
19,379
19,431
20,671
6,484
7,176
7,955
4,024
4,108
4,851
5,358
0
0
0
0
0
000005,3584,8514,1084,0247,9557,1766,48420,67119,43119,37918,15916,7951633293294954946606608263051301209041081471841,2191,2721,3271,000211164134000234
       Capital Lease Obligations 
0
0
0
0
0
164
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,198
2,987
2,839
2,457
2,070
2,622
2,121
2,770
3,800
3,901
3,641
3,484
3,338
3,134
2,986
2,947
3,625
3,507
3,353
2,170
2,136
2,099
2,0992,1362,1703,3533,5073,6252,9472,9863,1343,3383,4843,6413,9013,8002,7702,1212,6222,0702,4572,8392,9873,19800000000000000016400000
       Warrants
0
0
0
0
0
9,473
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000009,47300000
       Other Liabilities 
0
0
0
0
0
0
0
317
51
461
528
422
398
374
437
348
299
262
230
197
163
0
0
0
0
0
382
229
269
354
369
378
375
256
306
268
229
218
172
156
0
0
0
00015617221822926830625637537836935426922938200000163197230262299348437374398422528461513170000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
184
147
108
362
148
139
305
404
472
437
1,775
1,452
1,224
860
605
148
786
157
2,914
146
152
147
142
131
121
129
129
127
121
0
0
0
0001211271291291211311421471521462,9141577861486058601,2241,4521,77543747240430513914836210814718400000000000
       Deferred Long Term Liability 
0
0
0
0
296
0
0
0
0
0
0
422
398
374
348
319
291
262
230
197
163
0
0
0
0
0
234
74
113
207
222
0
0
0
0
0
0
0
0
0
0
0
0
00000000000022220711374234000001631972302622913193483743984220000002960000
> Total Stockholder Equity
168
168
0
-2,079
-8,066
-8,814
8,828
11,945
7,491
3,255
7,945
3,275
3,167
554
-2,138
3,760
1,401
9,300
6,399
4,030
3,309
4,339
1,827
-1,557
4,293
14,083
18,729
17,079
21,191
46,031
39,736
33,299
41,217
34,171
27,361
13,938
7,576
9,177
6,860
2,677
-11,562
-11,562
-11,668
-11,668-11,562-11,5622,6776,8609,1777,57613,93827,36134,17141,21733,29939,73646,03121,19117,07918,72914,0834,293-1,5571,8274,3393,3094,0306,3999,3001,4013,760-2,1385543,1673,2757,9453,2557,49111,9458,828-8,814-8,066-2,0790168168
   Common Stock
4
0
0
4
5
5
107
125
125
126
194
217
253
274
294
520
23
53
61
64
86
176
176
9
56
125
177
198
251
383
383
383
465
466
466
483
29
55
70
100
0
13
13
131301007055294834664664653833833832511981771255691761768664615323520294274253217194126125125107554004
   Retained Earnings -306,782-305,493-305,493-288,452-284,389-278,561-272,824-262,290-248,186-242,345-235,542-228,730-222,673-215,586-200,736-193,626-185,950-178,474-174,525-172,007-168,525-165,932-162,079-158,346-155,091-151,759-148,684-145,746-142,477-138,269-133,291-128,533-123,683-118,631-114,124-109,397-104,726-99,367-96,772-95,36700-91,101
   Capital Surplus 
0
0
0
0
0
90,548
113,447
121,216
121,491
121,761
131,412
131,591
136,199
138,547
140,047
148,994
150,115
161,044
161,449
162,330
165,314
170,104
170,190
170,449
178,780
192,410
204,154
208,892
219,129
259,766
260,028
0
0
0
0
0
0
0
0
0
0
0
0
000000000000260,028259,766219,129208,892204,154192,410178,780170,449170,190170,104165,314162,330161,449161,044150,115148,994140,047138,547136,199131,591131,412121,761121,491121,216113,44790,54800000
   Treasury Stock0000000000000000000000000000000000000000000
   Other Stockholders Equity 
89,266
0
0
89,341
87,960
90,548
113,447
104,219
121,491
121,759
131,412
131,591
136,199
138,547
140,046
148,987
150,115
161,006
161,429
162,311
165,314
170,094
170,175
170,441
178,780
192,410
204,154
208,506
219,129
259,766
260,028
260,245
275,708
275,949
276,206
277,407
281,167
288,326
291,935
291,706
0
293,992
295,094
295,094293,9920291,706291,935288,326281,167277,407276,206275,949275,708260,245260,028259,766219,129208,506204,154192,410178,780170,441170,175170,094165,314162,311161,429161,006150,115148,987140,046138,547136,199131,591131,412121,759121,491104,219113,44790,54887,96089,3410089,266



5.4. Balance Sheets

Currency in USD. All numbers in thousands.




5.5. Cash Flows

Currency in USD. All numbers in thousands.




5.6. Income Statements

Currency in USD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue3,418
Cost of Revenue-3,509
Gross Profit-91-91
 
Operating Income (+$)
Gross Profit-91
Operating Expense-15,598
Operating Income-30,749-15,688
 
Operating Expense (+$)
Research Development4,733
Selling General Administrative8,082
Selling And Marketing Expenses2,783
Operating Expense15,59815,598
 
Net Interest Income (+$)
Interest Income105
Interest Expense-1,839
Other Finance Cost-497
Net Interest Income-2,231
 
Pretax Income (+$)
Operating Income-30,749
Net Interest Income-2,231
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-32,669-15,465
EBIT - interestExpense = -17,385
-30,830
-30,830
Interest Expense1,839
Earnings Before Interest and Taxes (EBIT)-15,546-30,830
Earnings Before Interest and Taxes (EBITDA)-14,227
 
After tax Income (+$)
Income Before Tax-32,669
Tax Provision-0
Net Income From Continuing Ops-26,162-32,669
Net Income-32,669
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses19,107
Total Other Income/Expenses Net-15,2842,231
 

Technical Analysis of Opgen
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Opgen. The general trend of Opgen is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Opgen's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of OpGen Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 2.3 < 2.9 < 2.9.

The bearish price targets are: 1.75 > 1.72 > 1.65.

Tweet this
OpGen Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of OpGen Inc. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

OpGen Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of OpGen Inc. The current macd is -0.10444682.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Opgen price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Opgen. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Opgen price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
OpGen Inc Daily Moving Average Convergence/Divergence (MACD) ChartOpGen Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of OpGen Inc. The current adx is 24.69.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Opgen shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
OpGen Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of OpGen Inc. The current sar is 2.62062526.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
OpGen Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of OpGen Inc. The current rsi is 53.04. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
OpGen Inc Daily Relative Strength Index (RSI) ChartOpGen Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of OpGen Inc. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Opgen price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
OpGen Inc Daily Stochastic Oscillator ChartOpGen Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of OpGen Inc. The current cci is 79.02.

OpGen Inc Daily Commodity Channel Index (CCI) ChartOpGen Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of OpGen Inc. The current cmo is 22.39.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
OpGen Inc Daily Chande Momentum Oscillator (CMO) ChartOpGen Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of OpGen Inc. The current willr is -33.8028169.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Opgen is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
OpGen Inc Daily Williams %R ChartOpGen Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of OpGen Inc.

OpGen Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of OpGen Inc. The current atr is 0.20995319.

OpGen Inc Daily Average True Range (ATR) ChartOpGen Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of OpGen Inc. The current obv is 24,959,564.

OpGen Inc Daily On-Balance Volume (OBV) ChartOpGen Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of OpGen Inc. The current mfi is 74.26.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
OpGen Inc Daily Money Flow Index (MFI) ChartOpGen Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for OpGen Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-04-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-29MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-05-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-03MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-05-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-05-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-21BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-05-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-06-03BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-04RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-18RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-06-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-07-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-02STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-08BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-07-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-11STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-16MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-05STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-06STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-21STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-27STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-09-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-09STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-11MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

OpGen Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of OpGen Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.038
Ma 20Greater thanMa 502.024
Ma 50Greater thanMa 1002.481
Ma 100Greater thanMa 2003.061
OpenGreater thanClose2.060
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Opgen with someone you think should read this too:
  • Are you bullish or bearish on Opgen? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Opgen? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about OpGen Inc

I send you an email if I find something interesting about OpGen Inc.


Comments

How you think about this?

Leave a comment

Stay informed about OpGen Inc.

Receive notifications about OpGen Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.